全身化疗常可使晚期非小细胞肺癌(NSCLC)得到客观缓解,但对远期存活则影响甚微。现行常用方案有明显的毒副作用,且因需静脉给药,多有不便。本文作者设计了一个用于治疗晚期NSCLC的VP_(16)(鬼臼乙叉苷)和CTX(环磷酰胺)全口服方案。 病人与方法 病例收治标准是以前未接受化疗并 Systemic chemotherapy often results in objective remission of advanced non-small cell lung cancer (NSCLC), but has little effect on long-term survival. The current commonly used programs have obvious toxic and side effects and are inconvenient because of the need for intravenous administration. The authors designed a VP_(16) (Etoposide) and CTX (Cyclophosphamide) total oral regimen for the treatment of advanced NSCLC. Patients and Methods The criteria for the admission of patients were previously untreated and